MedDRA version: 14.1 Level: LLT Classification code 10010495 Term: Congenital heart disease NOS System Organ Class: 10010331 - Congenital, familial and genetic disorders
Conditions
Interventions
Trade Name: Solu-Medrol 40 mg/ml
Pharmaceutical Form: Concentrate and solvent for injection
Pharmaceutical form of the placebo: Infusion
Route of administration of the placebo: Intravenous use
Trade
Sponsors
Pertti Suominen
Pertti Suominen
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: ;Secondary Objective: ;Primary end point(s): | — |
Countries
Finland
Outcome results
None listed